chondrocyte phenotypes, respectively. We found the gene expression of ADAMTS9 by ATDC5 cells as a dual mode, both before the expression of type X collagen and after hypertrophic differentiation. The immunoreactivity of ADAMTS9 was observed in chondrocytes of proliferative a n d h y p e r t r o p h i c z o n e s i n t h e g r o w t h p l a t e . T h e population of ADAMTS9 positive cells decreased with age. The results of the present study suggest that ADAMTS9 might have a role in aggrecan cleavage around the chondrocytes to allow chondrocyte proliferation and hypertrophy.
Introduction
In the process of endochon dral os sificatio n, undifferentiated chondrocytes undergo cell proliferation and differentiation to become mature chondrocytes in the growth plate. They produce abundant extracellular matrices, mainly composed of aggrecan and type II collagen (Tsumaki et al., 1996) . When they differentiate to hypertrophic chondrocytes, they generate type X collagen and alkaline phosphatase (ALPase). With the cell death of the hypertrophic chondrocytes, the extracellular matrix is mineralized, and replaced by bone after vascular invasion. Matrix degrading enzymes, such as matrix metalloproteinases (MMPs) or aggrecanases are known to play important roles during these processes (Clare et al., 1995; . A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) is a family of metalloproteinase, and some
S u m m a r y . A d i s i n t e g r i n a n d m e t a l l o p r o t e i n a s e with thrombospondin motifs 9 (ADAMTS9) is known to influence aggrecan degradation in endochondral ossification, but its role has not been well understood.
In the present study, in vitro gene expression of ADAMTS9 was investigated by RT-PCR in ATDC5 cells in which experimentally chondrogenic differentiation had been induced. We also investigated the protein localization and gene expression pattern of ADAMTS9 in the tibia growth plate cartilage of male mice in a day 1 neonate, 7-week-old young adult, and a 12-week-old adult by immunohistochemistry and in situ hybridization and compared the results with the expression of proliferating cell nuclear antigen (PCNA) and type X collagen for the identification of proliferative and hypertrophic and fixed on day 1 neonate, at 7 weeks, or at 12 weeks by perfusion via the left ventricle with 4% paraformaldehyde in a 0.1 M phosphate buffer (pH7.4) at room temperature. After separation of the hind limbs, their skin was removed and the hind limbs were trimmed around the knee joint. They were immersed in the same fixative at 4 overnight and then decalcified by 10% EDTA in a 0.1 M phosphate buffer (pH 7.5) for 1 week by daily refreshing with shaking. After decalcification, specimens were dehydrated using graded concentrations of an ethanol series prior to embedding in Paraplast plus (Sigma, St Louis, MO, USA). Serial sections (7 m thickness) were cut and mounted on APS coated slides.
Cell cultures
The ATDC5, a mouse chondrosarcoma cell line, was obtained from the Riken Cell Bank (Tsukuba). Cells were cultured in a maintenance medium consisting of a 1:1 mixture of Dulbecco s modified eagle (DME) and Ham s F12 medium containing 5% fetal bovine serum (FBS) as described earlier (Shukunami et al., 1996) . The ATDC5 cells were plated at 6.4 10 4 cells /cm 2 in a 6-well plate with DMEM and chondrogenesis was induced by insulin (10 g/ml, Nacalai Tesque, Kyoto). The medium was replaced every other day. Cells were maintained at 37 in a humidified atmosphere of 5% CO2 in air.
Reverse transcription-polymerase chain reaction (RT-PCR)
For the determination of ADAMTS9 and type X collagen expression in ATDC5 cells, total RNA was prepared by using an RNeasy Lipid Tissue Mini Kit (QIAGEN, Hilden, Germany). The cDNA of ATDC5 cells at 0, 8, 14, 22, 28 , and 35 days were reverse transcribed from 1 g of the total RNA by a Quanti Tect Reverse Transcription Kit (QIAGEN, Hilden, Germany). A PCR procedure was performed according to Demircan s method (Demircan et al., 2005) . Primer sequences are listed in Table 1 . An RT-PCR analysis was performed using a Light Cycler Rapid Thermal Cycling system (Roche Diagnostics, Laval, Canada). The optimal cycle number was determined empirically in each case to maximize the sensitivity of quantifications. PCR products were electroporated in 1.5% agarose gels containing ethidium bromide.
Immunohistochemistry
Sections were irradiated on ice with a 360 W microwave to activate antigens after deparaffinization. Irradiation was performed using three cycles of two min irradiation with of them have been characterized by their aggrecanase activity which is responsible for aggrecan degradation in the endochondral ossification and also in joint inflammatory diseases (Malfait et al., 2002; Kevorkian et al., 2004; Naito et al., 2007) .
The structures of ADAMTSs are homologous to a disintegrin and metalloproteinase (ADAM) proteins, but they also contain at least 1 C-terminal thrombospondin type 1 (TSP1) repeat and are secreted rather than membrane bound (Porter et al., 2005) . ADAMTS1, 4, 5, 8, 9, 15 have been classified into three groups by their capacity to degrade aggrecan molecules as follows: aggrecanase-1 group includes ADAMTS1 and 4; aggrecanase-2 group includes ADAMTS5; and aggrecanase-3 group includes ADAMTS8, 9, and 15. Of these, ADAMTS4 and 5 exhibit the most powerful aggrecanase activities Tortorella et al., 1999 Tortorella et al., , 2001 Rogerson et al., 2008) . ADAMTSs and the MMPs reportedly play important roles in the metabolism in the extracellular matrix of the cartilage during the development and the progress of joint diseases (Martel-Pelletier et al., 2001; Arner et al., 2002; Chockalingam et al., 2004; Pásztói et al., 2009) . Although ADAMTSs are especially believed to be involved in the cellular growth, differentiation, and maturation of the growth plate chondrocytes, their roles in the endochondral ossification have not been completely elucidated (Demircan et al., 2005; Mitani et al., 2006; Hatipoglu et al., 2009a; Yaykasli et al., 2009) .
Thus, the present study was designed to investigate the gene expression and protein localization pattern of ADAMTS9 in the growth plate cartilage of the mouse tibia from neonate to 12 weeks of age using in situ hybridization and immunohistochemistry. ADAMTS9 mRNA expression was also confirmed by RT-PCR during the insulin-induced chondrogenesis of ATDC5 cells. Our results indicated that ADAMTS9 is expressed by chondrocytes and might be involved in the process of endochondral ossification by supporting the chondrocyte proliferentiation and hypertrophy with matrix degradation.
Materials and Methods

Animals and tissue preparation
A l l e x p e r i m e n t s w e r e u n d e r t a k e n a c c o r d i n g t o t h e G u i d e l i n e s a n d R e g u l a t i o n s f o r t h e A n i m a l Experimentation of Okayama University. Male ICR mice were used in this study. Newborn mice were maintained for up to 12 weeks.
The mice were sacrificed under general anesthesia,
Results
In vitro gene expression of ADAMTS9 and type X collagen during insulin-induced chondrogenesis in ATDC5 cells
The gene expression of ADAMTS9 was detected by PCR for comparison with the gene expression of type X collagen in insulin-induced chondrogenesis of ATDC5 cells up to 35 days (Fig. 1) . The gene expression of type X collagen was observed after 22 days of treatment. On the other hand, the gene expression of ADAMTS9 showed 15 sec intervals for cooling down by using a microwave. Polyclonal rabbit antibodies directed against ADAMTS9 (diluted to 1:200, Abcam, Cambridge, UK), proliferating cell nuclear antigen (PCNA) (diluted to 1:200, Santa Cruz Biotechnology, Inc., CA, USA), and type X collagen (diluted to 1:200, Santa Cruz Biotechnology, Inc., CA, USA) were used with Histofine ® Simple Stain Max-PO (Nichirei, Tokyo). To reduce non-specific background signals, sections were blocked with a normal serum. To block endogenous peroxidase activity, 1 mM sodium azide was added to a color reaction medium containing 3-3 -diaminobenzidine (DAB); this reaction was enhanced by adding 20 mM nickel chloride. After immunoreactions were completed, sections were counterstained with methylgreen.
In situ hybridization
The cDNA clone used for ADAMTS9 ribo probe synthesis was a generous gift from Dr. Suneel S. Apte. Ribo probes for type X collagen were prepared as described previously (Webster et al., 2003) . Labeled transcripts of mouse ADAMTS9 and type X collagen were synthesized either with T7 or Sp6 RNA polymerase with a digoxigenin labeled RNA labeling kit (Roche Diagnostics, Laval, Canada). Transcripts in sense orientation revealed no specific hybridization pattern. In situ hybridization was performed according to the method by Meyer et al. (1997) with minor modifications. Sections were deparaffinized and digested with 20 g/ml proteinase K (Sigma) for 10 min at room temperature. They were incubated with acetic anhydride (Triethanolamin, HCl in DW before use and then acetic anhydride was added) with vigorous agitation for 15 min at room temperature. After sections were treated with riboprobes in a buffer, they were incubated on slides at 55 overnight. Signals were visualized by a colorimetric reaction with nitroblue tetrazolium chloride (NBT) and 5-bromo-4-chloro-3-indolylphosphate (BCIP) at 4 for 4 days. The sections were counterstained with methylgreen after the color reaction. The gene expression of type X collagen was used as a marker of hypertrophic chondrocytes. The gene expression of type X collagen was observed after 22 days of treatment. The gene expression of ADAMTS9 showed two peaks: the first peak was found from 8 to 14 days after induction, and the second peak was found from 28 to 35 days after induction.
Table 1. Primers for RT-PCR
Oligonucleotide sequence (5 --3 ) Accession No. ADAMTS9 Forward GGA CAA GTG AAG GAC ATC C NM-175314 Reverse TAG GCA GAG GAT ACC GAA GG (Jungers et al., 2005 ) Type X Forward GCA GCA TTA CGA CCC AAG AT NM-009925 Collagen Reverse TCT GTG AGC TCC ATG ATT GC (Nakajima et al., 2009 ) GAPDH Forward CAA CTG CCA ACG TGT CAG TGG Reverse AAG GTG GAG GAG TGG GTG TCG chondrocytes in both proliferative and hypertrophic zones (Fig. 2B ). The signal of immunoreaction for ADAMTS9 was more intense in chondrocytes of the hypertorophic zone than in those of the proliferative zone.
Comparison of the gene expression and the immunoreactivities of ADAMTS9 in the tibia of neonatal mice in vivo
The gene expression of ADAMTS9 was observed in chondrocytes of proliferative and hypertrophic zones in the growth plate cartilage of normal neonates but not in chondrocytes of the reserve zone (Fig. 3A, C) . This expression pattern corresponds closely to the ascending expression of ADAMTS9 found by PCR in ATDC5 cells 8 days after the induction of chondrogenesis by insulin (Fig. 1) . By immunohistochemistry, the localization of ADAMTS9 positive cells also showed a pattern similar to the gene expression pattern mentioned above (Fig. 3 B,  D ). double peaks: the first peak of the gene expression of ADAMTS9 was found from 8 to 14 days, and the second peak was found from 28 to 35 days after induction. The gene expression of ADAMTS9 at the first peak was more intense than that at the second peak.
Comparison of immunoreactivities of ADAMTS9, type X collagen, and PCNA in 7 week-old adult mice
In the growth plate cartilage of the 7-week-old mouse tibia, signals for PCNA were observed in chondrocytes of the proliferative zone in which chondrocytes were organized into distinct columns (Fig. 2D) . A positive immunoreaction for type X collagen was found only in chondrocytes of the hypertrophic zone, which contained greatly enlarged cells (Fig. 2C) . Cells in the reserve zone did not show any signals for PNCA nor for type X collagen. The widths of the positive cells for both PCNA and type X collagen in young adult mice were narrower than those of neonates ( data not shown). Immunoreactivity for ADAMTS9 was observed in found by PCR of insulin-induced chondrogenesis of ATDC5 cells after day 28 (Fig. 1) . The pattern of immunoreactivities of ADAMTS9 was similar to the gene expression pattern of ADAMTS9, as mentioned above (Fig. 4 B, D) .
Comparison of the gene expression and the immunoreactivities of ADAMTS9 in the tibia of 12-week-old adult mice in vivo
Positive hybridization signals for ADAMTS9 were observed in chondrocytes of hypertrophic zone in the
Comparison of the gene expression and the immunoreactivities of ADAMTS9 in the tibia of young adult mice in vivo at 7 weeks of age
The gene expression of ADAMTS9 was observed in chondrocytes of both the proliferative and hypertrophic zones but not in chondrocytes of the reserve zone in normal 7-week-old adult mice (7 weeks, Fig. 4A, C) . The endochondral ossification was still continuous at this age although the zone of immature chondrocytes was not so thick as that of 0-d or 1-week old mice. This expression was in accord with the second peak of ADAMTS9 growth plate cartilage in 12-week-old adult mice (12 weeks, Fig. 5 A, C). There were fewer small chondrocytes that could still be observed at the top of the growth plate at 12 weeks; however, these were immunohistochemically negative for both PCNA and ADAMTS9 while the immunoreactivity for ADAMTS9 showed a pattern similar to the ADAMTS9 gene expression pattern mentioned abo ve (Fig. 5B, D) , the strength of the immunohistochemical signals did decrease with age.
Age related differences in the localization of ADAMTS9
Age -re la te d d if f e r e n c e s i n im m u n o r e a c t i vity for ADAMTS9 were investigated in the growth plate cartilage of the tibia from neonates to 12-week-old adult mice (Fig. 3 -5 ). The population of ADAMTS9-positive cells in normal neonates in both zones of the growth plate cartilage were as follows ( Fig. 6 ): 71 -100% positive cells in the proliferative chondrocyte zone, and 71 -100% in the hypertrophic chondrocyte zone. Both zones of the growth plate cartilage of neonates were localized ubiquitously. The immunoreaction for ADAMTS9 in 7-week-old young adults exhibited the localized pattern mostly in chondrocytes of the 71 -100% hypertrophic zones, but this was only slightly expressed in chondrocytes of the 31 -70% proliferative zone in the growth plate cartilage. On the other hand, the population of ADAMTS9-positive cells in 12-week-old adult mice were 11-30% hypertrophic zone in the growth plate cartilage. No positive immunoreaction was seen in chondrocytes of the reverse zone. The signal intensity of both the gene expression and the immunoreactivities of ADAMTS9 decreased with age. Undifferentiated mesenchymal cells, osteoclasts, and osteoblasts expressed no ADAMTS9 signal at any age.
Discussion
The ADAMTS family consists of 19 members, and ADAMTS1, 4, 5, 8, 9 , and 15 are capable of cleaving an aggrecan molecule (Caterson et al., 2000; Porter et al., 2005; Hatipoglu et al., 2009b) . Their aggrecanase activity is known to responsible for aggrecan degradation in joint inflammatory diseases (Nagase et al., 2003; Kevorkian et al., 2004; Demircan et al., 2005; Bondeson et al., 2008) . It has also been reported that expressions of ADAMTS1, 4, and 5 were found in the growth plate of the rat tibia (Jungers et al., 2005; Mitani et al., 2006) , although there were no morphological difference between wild type and targeted mutant mice against ADAMTS1, 4, or 5 genes (Glasson et al., 2004; Little et al., 2005; Stanton et al., 2005) . In the present study, we demonstrated for the first time that ADAMTS9 is expressed at mRNA and protein levels in the mouse tibia growth plate. The present study investigated the gene expression of ADAMTS9 in vitro after the induction of chondrogenesis by insulin in ATDC5 cells and found that the gene expression of ADAMTS9 was exhibited two peaks, the first peak being observed from day 8 to day 14 after treatment, and the second peak being observed from day 28 to day 35. ADAMTS9-negative ATDC5 during the first week of cell culture might correspond to the chondrocytes of the reserve zone. As type X collagen expression, a marker for the hypertrophic chondrocyte, was detected after day 22, chondrocytes at the first peak correspond to the proliferative zone, and those of the second peak to the hypertrophic phenotype. The gene expression of the first peak was significantly more intense than that of the second peak, suggesting a higher expression of ADAMTS9 by chondrocytes in the proliferative zone than the hypertrophic zone. It is considered that ADAMTS9 may provide space for the migration of proliferating chondrocytes as well as expanding chondrocytes during terminal differentiation. We also investigated age-dependent differences in the gene expression and protein localization of ADAMTS9 during growth of the tibia from neonates to 12-weekold adult, in comparison with the distribution of PCNAand type X collagen-positive chondrocytes. The results showed that the expression and localization of ADAMTS9 was broadly observed in chondrocytes of both the proliferative and hypertrophic zones in the growth plate cartilage in neonates and 7-week-old young adult mice (Fig. 2 -5) . In 12-week-old adult mice, the expression of ADAMTS9 was restricted to chondrocytes of the hypertrophic zone in the growth plate cartilage. There were fewer small chondrocytes still observed at the top of the growth plate at 12 weeks; however, they were immunohistochemically negative for both PCNA and ADAMTS9. These results suggest that the ADAMTS9 expression might not depend on the shape of the chondrocyte but on its developmental stage. Our findings also showed that, although the localization pattern of PCNA overlapped with that of ADAMTS9 in neonates, the localization of PCNA was a little broader than that of ADAMTS9 at 12 weeks. The fact that signals for PCNA were found only in chondrocytes of the proliferative zone in neonates and at 7 weeks, but not at 12 weeks, might indicate that the growth activity of the growth plate may decrease around 12 weeks of age in mice. Because PCNA is known as a cell cycle related factor (Christov et al., 1975) , the overlapped expression of PCNA and ADAMTS9 might indicate that the role of ADAMTS9 is not only one of the aggrecanase but also a factor related to cell proliferation.
I t w a s r e p o r t e d t h a t A D A M T S 1 , 4 , 5 , 9 h a v e aggrecanase activities (Clark et al., 2000; Arner et al., 2002) while ADAMTS9 has a relatively weaker aggrecanase activity than the others (Stanton et al., 2005; Zeng et al., 2006; Koo et al., 2007) . Mitani et al. (2006) investigated the expression patterns of ADAMTS1, 4, and 5 in the rat mandibular condylar cartilage, and articular and growth plate cartilage and concluded that ADAMTS5 might mainly contribute to the extracellular matrix metabolism in the growth plate and condylar cartilage during growth. In contrast ADAMTS1 and ADAMTS4 may be involved in the extracellular matrix turnover in the articular cartilage in relation to ADAMTSs specific substrates such as aggrecan, brevican, and versican. In the present study, the gene expression and protein localization of ADAMTS9 showed patterns similar to those of ADAMTS5. In addition, it was reported that there were no genotype-related phenotype differences between ADAMTS4/5 double-knockout and wild type mice up to 1 year of age (Majumdar et al., 2007) . These results suggest that ADAMTS4/5 are not indispensable aggrecanases for endochondral ossification. On the other hand, no phenotype of targeted mutants of ADAMTS9 has been reported yet. The aggrecanolytic activity of ADAMTS9 weaker than that of ADAMTS4/5 might have an advantage in the relatively slow progression of cartilage growth. In addition to the results of our finding on the gene expression of ADAMTS9 in growth plate chondrocytes, targeted gene silencing of ADAMTS9 in vitro would add to the functional importance of this aggrecanase in the process of endochondral ossification.
